Reckitt Hit With Stock Drop Suit Over $1.4B Opioid Probe Deal

British pharmaceutical company Reckitt Benckiser Group PLC was hit with a stock drop suit Monday in New Jersey federal court, shortly after announcing it will pay U.S. authorities up to $1.4 billion to settle an investigation into an opioid addiction medication…

Read this piece in its entirety at Law360.

Comments

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s